Borrelli, Francesca <br/><br/>
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.  [electronic resource] 

 -  Biochemical pharmacology  May 2013 
 - 1306-16 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2013.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Cannabinoids--pharmacology<br/>Cell Line<br/>Colitis--drug therapy<br/>Colon--drug effects<br/>Cyclooxygenase 2--metabolism<br/>Epithelial Cells--drug effects<br/>Inflammatory Bowel Diseases--drug therapy<br/>Interferon-gamma--metabolism<br/>Interleukin-10--metabolism<br/>Interleukin-1beta--metabolism<br/>Intestinal Mucosa--drug effects<br/>Ki-67 Antigen--metabolism<br/>Macrophages, Peritoneal--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>Nitric Oxide Synthase Type II--metabolism<br/>Permeability<br/>Peroxidase--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Receptor, Cannabinoid, CB1--metabolism<br/>Receptor, Cannabinoid, CB2--metabolism<br/>Superoxide Dismutase--metabolism